Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Mesa Laboratories's operating assets for the quarter that ended in Mar. 2026 was $400.8 Mil. Mesa Laboratories's operating liabilities for the quarter that ended in Mar. 2026 was $86.3 Mil. Mesa Laboratories's Total Assets for the quarter that ended in Dec. 2025 was $434.8 Mil. Therefore, Mesa Laboratories's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.72.
Mesa Laboratories Scaled Net Operating Assets Related Terms
Mesa Laboratories Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories Scaled Net Operating Assets Chart
MLAB vs AERG, MVIS, ARBE: Scaled Net Operating Assets Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Scaled Net Operating Assets vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.72 mean?
Mesa Laboratories (MLAB) has a Scaled Net Operating Assets of 0.72 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Mesa Laboratories and its competitors.
Is Mesa Laboratories' Scaled Net Operating Assets too high?
Mesa Laboratories' current Scaled Net Operating Assets is 0.72. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Scaled Net Operating Assets compare to AERG and MVIS?
Mesa Laboratories' Scaled Net Operating Assets of 0.72 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Hardware company?
A good Scaled Net Operating Assets depends on the Hardware industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Mesa Laboratories and its competitors. Mesa Laboratories's current Scaled Net Operating Assets is 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.05, compared to a current price of $98.18 — trading 15.4% below its estimated fair value. The current Scaled Net Operating Assets is 0.72. Mesa Laboratories' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Scaled Net Operating Assets is 0.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $98.18 is trading 15.4% below its estimated GF Value™ of $116.05.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
Scaled Net Operating Assets: 0.72
GF Value™: $116.05 vs. price of $98.18 (15.4% below fair value)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score
Get the complete analysis for MLAB
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
